Matresa

Investor: SFC Capital

Matresa, a health-tech startup founded by former nurse Mari-Carmen Sanchez-Morris, has successfully raised £315,000 in pre-seed funding. This capital injection, led by SFC Capital, will be used to accelerate the development and rollout of Matresa’s platform, which aims to provide personalised, continuous care for mothers from preconception through postpartum recovery.Summary of transaction details:Value: £315,000Sector: HealthTech, Maternal CareAdvisor: Not disclosedKey Entities: Matresa (Target), SFC Capital (Lead Investor)Location: UKNote: This pre-seed funding underscores the growing market recognition for innovative solutions addressing the UK's maternal health challenges. Matresa's approach, combining clinical expertise, behavioural science, and AI, seeks to improve maternal outcomes, reduce healthcare costs, and enhance female workforce participation by supporting mothers through critical transitional periods.

Investor: SFC Capital

London-based maternal health AI startup Matresa has successfully raised £315,000 in a pre-seed funding round led by SFC Capital. This investment aims to support Matresa's mission to combat the growing maternal health crisis in the UK by scaling its technology-driven platform.Summary of transaction details:Value: £315,000Sector: Healthcare & Biotech (AI)Advisor: Not disclosedKey Entities: Matresa (Target), SFC Capital (Lead Investor)Location: London, UKNote: This pre-seed funding round highlights investor confidence in Matresa's AI-powered platform, which combines clinical expertise and behavioural science to offer personalised support for women during pregnancy and postpartum. The investment also addresses a critical societal challenge by supporting a female-founded venture in the underserved maternal healthcare sector, demonstrating a growing trend towards impactful technology solutions.

Investor: SFC Capital

Matresa, a maternal health AI company based in London, has successfully closed a pre-seed funding round, raising £315,000. The investment was led by SFC Capital and will be instrumental in advancing Matresa's personalised, technology-driven maternal health platform.Summary of transaction details:Value: £315,000Sector: Healthcare & BiotechAdvisor: Not mentionedKey Entities: Matresa (Target), SFC Capital (Lead Investor)Location: London, UK (Target operating location)Note: This funding injection underscores investor confidence in innovative solutions addressing critical healthcare challenges. The capital will enable Matresa to accelerate product development and market penetration, addressing the urgent need for enhanced maternal care in the UK.